Outlook Therapeutics, Inc. OTLK
0.40 USD -0.01 (-1.69%)
Regular-session close
0.38 -0.02 -5.14%
Pre-market · Nov 20, 5:26 AM ET
0.3845 Day range 0.4472
0.161 52-week range 2.54
- YTD
- -74.62%
- 1 year
- -78.67%
News
benzinga.com This Outlook Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings…
benzinga.com This Outlook Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday Analysts initiated coverage: Anthropic (ANT) Buy/$150 and Outperform/$135; LASE Buy/$2; OTLK Overweight/$4; KINS Overweight/$24.benzinga.com Piper Sandler Initiates Coverage On Outlook Therapeutics with Overweight Rating, Announces Price Target of $4 Piper Sandler analyst David Amsellem initiates coverage on Outlook Therapeutics (NASDAQ:OTLK) with a Overweight rating and announces Price Target of $4.
